🔗 Share this article

This year's Nobel Prize in Physiology or Medicine was awarded for transformative findings that clarify how the body's defense network targets dangerous infections while protecting the body's own cells.

Three renowned researchers—from Japan Prof. Sakaguchi and American experts Mary Brunkow and Fred Ramsdell—share this honor.

Their research uncovered specialized "sentinels" within the defense system that eliminate malfunctioning defense cells capable of attacking the organism.

The findings are now paving the way for innovative treatments for immune disorders and malignancies.

These winners will share a monetary award worth 11 million Swedish kronor.

Crucial Findings

"Their work has been decisive for understanding how the body's defenses functions and why we don't all develop severe self-attack conditions," stated the chair of the Nobel Committee.

The trio's research explain a core question: In what way does the defense system protect us from countless invaders while leaving our healthy cells unharmed?

The body's protection system uses white blood cells that scan for signs of infection, even viruses and germs it has never encountered.

Such defenders utilize sensors—called recognition units—that are generated randomly in a vast number of variations.

That gives the immune system the capacity to fight a wide array of threats, but the unpredictability of the mechanism inevitably creates immune cells that may target the body.

Security Guards of the Body

Researchers previously understood that some of these problematic defense cells were eliminated in the immune organ—where white blood cells develop.

This year's Nobel Prize recognizes the identification of T-reg cells—described as the body's "security guards"—which travel through the system to neutralize any immune cells that attack the body's own tissues.

It is known that this mechanism fails in self-attack conditions such as juvenile diabetes, MS, and rheumatoid arthritis.

The Nobel panel added, "These findings have laid the foundation for a novel area of investigation and spurred the development of new treatments, for instance for tumors and immune disorders."

Regarding cancer, regulatory T-cells block the system from attacking the growth, so studies are aimed at lowering their quantity.

In self-attack disorders, experiments are exploring increasing T-reg cells so the organism is not being harmed. A similar method could also be effective in minimizing the chances of organ transplant rejection.

Innovative Studies

Professor Sakaguchi, of Osaka University, performed experiments on mice that had their thymus extracted, causing autoimmune disease.

He showed that injecting immune cells from other mice could prevent the illness—implying there was a mechanism for preventing defenders from harming the body.

Mary Brunkow, affiliated with the a research center in Seattle, and Dr. Ramsdell, now at a biotech firm in a California city, were studying an genetic autoimmune disease in mice and people that led to the discovery of a gene vital for the way regulatory T-cells operate.

"The pioneering work has revealed how the immune system is kept in check by T-reg cells, stopping it from accidentally targeting the healthy cells," commented a leading physiology specialist.

"This research is a remarkable illustration of how basic biological study can have broad implications for human health."